About Us

Our Story

Committed to the Ophthalmic Excellence

Ms Aseel Hamoud Bedan FRCS-G, MRSCI, EBO, ICO, MBChB is a consultant ophthalmic surgeon at Western Eye Hospital Imperial College Healthcare NHS Trust. She works at Hendon Hospital Circle Health Group.

Her interests include treatment for cataract, medical retinal diseases. She is a skilled surgeon and has done over than 4000 eye surgeries.

Upon her career, she worked in Western Eye Hospital Imperial College NHS Trust, Ashford & St. Peter’s Hospital NHS Foundation Trust, Maidstone & Tunbridge Wells NHS Trust in Kent, Royal Victoria Eye & Ear Hospital in Dublin, Cork University Hospital, and University Hospital Limerick.

Our Values

Our Work is Heavily Shaped by our Core Values

01.

Professional Membership

General Medical Council – Number 7095890, specialist registration.
European Society of Cataract and Refractive Surgeons – Member
European Society of Retina Specialists – Member
American Academy of Ophthalmology – Member
The Association for Research in Vision and Ophthalmology – Member

02.

Areas of interest

Her special interests include routine/ complex cataract surgery.
Diabetic eye disease including Argon & Micro-pulse laser treatment, anti-VEGF & steroid injection with faricimab, elyea, lucentis, ozurdex and iluvien.
Medical retina diseases including age-related macular degeneration with OCT, FFA, ICG, intravitreal injection therapy with Anti-VEGF and Dexamethasone.
Retinal vein occlusion management with intravitreal injections and laser.
Central serous retinopathy treatment.
General ophthalmology.

03.

Peer Reviewed Publications

Peer Reviewed
Publications

Paper Presentations
at National Meetings

Poster Abstracts
at International Meetings

Poster Abstracts
at Regional Competition

04.

Publications

Uveitis Following Intravitreal Injections of Faricimab: A Case Report. https://www.tandfonline.com/doi/full/10.1080/09273948.2023.2293925. Published Dec. 2023.
‘Uveitis Following Intravitreal Injections of Faricimab: A Case Report’.
Ocular Immunology and Inflammation. Full article: Uveitis Following Intravitreal Injections of Faricimab: A Case Report (tandfonline.com). December 2023.
‘Characterizing The White Dot Syndromes, Atypical Presentation Of Inflammatory Chorioretinopathy During The Covid-19 Dilemma -Case Presentation’. EC Ophthalmology Volume 14 Issue 5 – 2023: Ecronicon – EC Ophthalmology, March 2023
‘Efficacy of Dexamethasone Sustained Released Implant in Treatment of Diabetic Macular Oedema: A Study during the COVID-19 Pandemic’, International Journal of Ophthalmic Pathology: Efficacy of Dexamethasone Sustained Released Implant in Treatment of Diabetic Macular Oedema: A Study during the COVID-19 Pandemic | SciTechnol . April 2023.
Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) in Diabetic Macular Oedema: A Case Series studySafety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) in Diabetic Macular Oedema: A Case Series study. | IOVS | ARVO Journals. June 2023.
‘Progression and Incidence of Geographic Atrophy in Patients with Wet Age-Related Macular Degeneration undergoing Anti- VEGF Therapy’. Progression and Incidence of Geographic Atrophy in Patients with Wet Age-Related Macular Degeneration undergoing Anti- VEGF Therapy | SciTechnol. March 2018.
Progression of Geographic Atrophy in Patients with Wet Age-Related Macular Degeneration Undergoing Anti-VEGF Therapy Progression of Geographic Atrophy in Patients with Wet Age-Related Macular Degeneration Undergoing Anti-VEGF Therapy | IOVS | ARVO Journals. June 2017.
Subthreshold Micropulse Laser Treatment in Diabetic Macular Oedema. ECOP-13-00932.pdf (ecronicon.org). ECOP-13-00932.pdf (ecronicon.net). Sep. 2022
Melanocytoma, case report-EURETINA 2022. ECOP-13-00933.pdf (ecronicon.net)
Three-year Outcomes of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Wet ARMD at the Western Eye Hospital | SciTechnol. Three-year Outcomes of a Treat-and-Extend Regimen of Intravitreal Aflibercept for Wet ARMD at the Western Eye Hospital | SciTechnol. Mar. 2018
“Ocular Findings of Down’s Syndrome in Iraq” Published in the Journal Faculty of Medicine Baghdad 2006; vol. 48, No.1. ocular findings of down’s syndrome in Iraq | Journal of the Faculty of Medicine Baghdad (uobaghdad.edu.iq)
Subthreshold Micropulse Yellow Laser Treatment for Central Serous Chororioretinopathy, Subthreshold Micropulse Yellow Laser Treatment for Central Serous Chorioretinopathy | SciTechnol. May 2018.
Bilateral choroidal metastases as the presenting manifestation of lung adenocarcinoma in a young, non-smoking female. ECOP-13-00933.pdf (ecronicon.net). Sep. 2022.
Subthreshold Micropulse Laser Treatment in Diabetic Macular Oedema. Subthreshold Micropulse Laser Treatment in Diabetic Macular Oedema | IOVS | ARVO Journals. June 2022.
Half Fluence Photodynamic Therapy PDT in Treating Chronic Central Serous Chorioretinopathy CSCR Patients. (PDF) Half Fluence Photodynamic Therapy PDT in Treating Chronic Central Serous Chorioretinopathy CSCR Patients (researchgate.net). May 2019.
Untargeted large spot half-fluence photodynamic therapy for chronic central serous chorioretinopathy.Untargeted large spot half-fluence photodynamic therapy for chronic central serous chorioretinopathy | IOVS | ARVO Journals. July 2018.
Real-world outcomes in patients with diabetic macular oedema treated with faricimab. Accepted for ARVO 2024.
A case Presentation of Viral Related Acute Retinal Pigment Epitheliitis. EURETINA 2023.
unusual presentation of a case of syphilitic posterior uveitis. EURETINA 2023.
Real-world short-term results of using Faricimab in treating DMO in Western Eye Hospital. EURETINA 2023.
Real-world outcomes of intravitreal Dexamethasone implant in Retinal Vein Occlusion. EURETINA 2023.
Anatomic and functional outcomes of phacoemulsification combined with Dexamethasone sustained release intravitreal implant for patients with cataract and Diabetic Macular Oedema. EURETINA 2023.
Safety and Efficacy of Dexamethasone Intravitreal Implant (Ozurdex) in Diabetic Macular Oedema: A Case Series Study, ARVO 2023.
Efficacy of Dexamethasone sustained released implant in Treatment of Diabetic Macular Oedema, a Study During the Covid-19 Pandemic – EURETINA 2022.
Melanocytoma, case report-EURETINA 2022.
characterizing the White dot syndromes, atypical presentation of inflammatory chorioretinopathy during the Covid-19 dilemma – case presentation -EURETINA 2022.
Subthreshold Micropulse Laser Treatment in Diabetic Macular Oedema-ARVO 2022.
One year real-world outcomes of anti-VEGF therapy in neovascular age related macular degeneration EURETINA 2020.
A unique case of bilateral choroidal metastases as the presenting manifestation of lung EURETINA 2020.
Fluocinolone Acetonide Intravitreal Implant 0.19 mg: A Review in Diabetic Macular Oedema. A poster presented in Euretina 2018.
Untargeted large spot half-fluence photodynamic therapy for chronic central serous chorioretinopathy, a poster presented in ARVO 2018.
Three Years Out-come of Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Oedema in Maidstone Hospital, UK. A poster presented in Euretina winter meeting 2018.
Advances in interventions for chronic and recurrent central serous chorioretinopath (CSCR), a poster presented in Euretina winter meeting 2018.
Three years outcome of fluocinolone acetonide intravitreal implant for diabetic macular oedema in Maidstone Hospital, UK. A poster presented in Euretina winter meeting 2018.
Long-term outcomes of photodynamic therapy in chronic central serous retinopathy. A poster presented in Euretina winter meeting 2018.
Sub threshold laser Treatment for Central Serous Chororioretinopathy, a poster presented in Euretina 2017.
Chronic central serous chorioretinopathy treated with Spironolactone, a poster presented in Euretina 2017.
Three-year outcomes of a Treat-and-Extend regimen of intravitreal Aflibercept for wet ARMD at the Western Eye Hospital, a poster presented in Euretina 2017.
Progression and Incidence of Geographic Atrophy in Patients with Wet Age-Related Macular Degeneration undergoing AntiVEGF Therapy, a poster presented in ARVO 2017.
Audit of wet AMD patients treated with IV Ranibizumab over 6-12 months, a poster resented in Ophthalmologica Belgica Congress 2017.
Dual Branch Retinal Vein Occlusion in one eye-case presentation, a poster resented in Ophthalmologica Belgica Congress 2017.
Audit on treatment of macular oedema in CRVO with anti-VEGF at the WEH, a poster presented in the Retinal Medical Audit Meeting, London 2016.

05.

Researches

LEAVO study 10/2016. Aim of research: To monitor the response of CMO in CRVO to various types of anti VEGF treatment. Conclusions/Actions: Double-blind randomised controlled trial comparing the clinical and cost effectiveness of intravitreal therapy with LUCENTIS vs AVASTIN vs EYLEA for Macular Oedema due to CRVO.
SAFARI date 12/2016. Aim of research: evaluating the efficacy and safety of switching from intravitreal Aflibercept to Ranibizumab.
Conclusions/Actions: Prospective, open-label, uncontrolled, European Study in patients with neovascular Age-related macular degeneration, evaluating the efficacy and safety of switching from intravitreal Aflibercept to Ranibizumab.
DRAKO Study, date 12/2016. Aim of research: Assess the effectiveness of intravitreal aflibercept in patients with visual impairment due to diabetic macular oedema. Conclusions/Actions: An observational study to assess the effectiveness of intravitreal aflibercept in routine clinical practice in patients with visual impairment due to diabetic macular oedema.

06.

Teaching Experience

Teaching lecturer in West London Ophthalmology Teaching North West Thames Region
Teaching lecturer in KSS Regional Ophthalmology Teaching (Kent, Surry, Sussex)
Special Lecturer/Registrar in University College Dublin 2014-2015.

Call Today

074 7018 5991

Secretary Moe Shlash

074 70185 991